View in EDS HTML Full Text PDF Full Text

Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.

Saved in:
Bibliographic Details
Title: Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.
Authors: Sharma, Raman1 (AUTHOR), Sharma, Hema2 (AUTHOR), Jones, Siôn2 (AUTHOR), Borghini-Fuhrer, Isabelle3 (AUTHOR), Domingo, Gonzalo J.4 (AUTHOR), Gibson, Rachel A.1 (AUTHOR) rachel.a.gibson@gsk.com, Rolfe, Katie1 (AUTHOR), Tan, Lionel2 (AUTHOR), Fiţa, Ioana Gabriela2 (AUTHOR), Chen, Chao2 (AUTHOR), Bird, Panayota2 (AUTHOR), Pingle, Anup5 (AUTHOR), Duparc, Stephan3 (AUTHOR)
Source: Malaria Journal. 5/13/2024, Vol. 23 Issue 1, p1-6. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14752875
DOI:10.1186/s12936-024-04924-z